Clinical trials: Isolated Artery Aneurysms (IAA)

Aorto-iliac Occlusive Disease (AIOD), Visceral Artery Occlusive Disease (VAOD)

GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis Post-Market Clinical Follow-Up (PMCF) Observational Registry (RE-PROVE)

• Recruiting
• Age: 18 years and older
• Observational study
• Medical device

Collect real-world post-market clinical follow-up data on subjects treated with the Reduced Profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (Reduced Profile VBX Stent Graft-BXB)

Conditions

Aorto-iliac Occlusive Disease (AIOD), Visceral Artery Occlusive Disease (VAOD), Isolated Artery Aneurysms (IAA), Trauma or Iatrogenic Vessel Injury

Trial name

NCT07279649

Testing

Reduced Profile GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (Reduced Profile VBX Stent Graft-BXB)

Where

Germany

Volunteers

240 people

Sponsor

W.L.Gore & Associates